Brief: Neurizon Therapeutics Says Michael Thurn Resigns As Managing Director And CEO
16/03/2026 01:06
March 16 (Reuters) - Neurizon Therapeutics Ltd NUZ.AX: MICHAEL THURN RESIGNS AS MANAGING DIRECTOR AND CEO SERGIO DUCHINI TO ASSUME ROLE OF EXECUTIVE CHAIR UNTIL NEW CEO APPOINTED Further company coverage: NUZ.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Neurizon Therapeutics
See all newsAustralia's Neurizon Therapeutics jumps on deal with US firm
Brief: Neurizon Therapeutics Executes Long-Term Supply Agreement With Elanco
Brief: Neurizon Therapeutics Receives Ethics Approval For Phase 1 Nuz-001 Oral Liquid Formulation Study
Brief: Neurizon Therapeutics Announces Placement Of Entitlement Offer Shortfall To Raise ~A$2.7 Million
Brief: Neurizon Therapeutics Says Michael Thurn Resigns As Managing Director And CEO